Company Filing History:
4 out of 850 
2 out of 1,746 
2 out of 5,450 
Years Active: 2008-2011
Title: Karen Lu: Innovator in Cancer Research
Introduction
Karen Lu is a prominent inventor based in Houston, TX (US), known for her significant contributions to cancer research. With a total of 4 patents, she has made strides in identifying markers that can help determine tumor sensitivity to therapeutic agents. Her work is pivotal in advancing cancer treatment methodologies.
Latest Patents
One of her latest patents focuses on compositions and methods for the identification, assessment, prevention, and therapy of human cancers. This invention is directed towards identifying markers that can indicate whether tumors are sensitive or resistant to specific therapeutic agents. It features a variety of 'sensitivity markers' that are predominantly expressed in cell lines sensitive to treatment, while being minimally expressed in resistant cells. Additionally, the invention includes 'resistance markers' that are expressed in resistant cell lines but not in sensitive ones. This innovative approach also encompasses marker sets that can predict patient responses to treatment.
Career Highlights
Throughout her career, Karen Lu has worked with notable organizations such as Millennium Pharmaceuticals Limited and the Mayo Foundation for Medical Education and Research. Her experience in these institutions has enriched her expertise in cancer research and therapeutic development.
Collaborations
Karen has collaborated with esteemed colleagues, including Edwin A. Clark and Lynn C. Hartmann, further enhancing her research endeavors and contributions to the field.
Conclusion
Karen Lu's innovative work in cancer research exemplifies her dedication to improving therapeutic outcomes for patients. Her patents and collaborations reflect her commitment to advancing medical science and patient care.